Growth Metrics

Becton Dickinson (BDX) Net Income towards Common Stockholders (2009 - 2026)

Becton Dickinson (BDX) reported Net Income towards Common Stockholders of -$274.0 million for Q1 2026, down 282.67% year-over-year from $150.0 million in Q1 2025, and down 171.73% on a QoQ basis from $382.0 million in Q4 2025.

Becton Dickinson (BDX) has 18 years of Net Income towards Common Stockholders data on file, last reported at -$274.0 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 282.67% year-over-year to -$274.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 12.31% YoY) and the FY2025 annual result came in at $1.7 billion, down 1.58% from the prior year.
  • Net Income towards Common Stockholders eased to -$274.0 million in Q1 2026 per BDX's latest filing, from $382.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $574.0 million in Q2 2025 and bottomed at -$274.0 million in Q1 2026.
  • The 5-year median for Net Income towards Common Stockholders is $392.0 million (2023), against an average of $340.6 million.
  • The widest annual swing landed in 2024, when Net Income towards Common Stockholders soared 270.37%; it then sank 282.67% in 2026.
  • Tracing BDX's Net Income towards Common Stockholders over 5 years: stood at $486.0 million in 2022, then tumbled by 42.18% to $281.0 million in 2023, then advanced by 7.83% to $303.0 million in 2024, then climbed by 26.07% to $382.0 million in 2025, then sank by 171.73% to -$274.0 million in 2026.
  • Per Business Quant, the three latest BDX Net Income towards Common Stockholders figures stand at -$274.0 million (Q1 2026), $382.0 million (Q4 2025), and $493.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -274.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 398.73 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 135.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 13.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 130.80 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 112.77 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 72.77 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn 8.33 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -274.00 Mn
Dec 31, 2025 382.00 Mn
Sep 30, 2025 493.00 Mn
Jun 30, 2025 574.00 Mn
Mar 31, 2025 150.00 Mn
Dec 31, 2024 303.00 Mn
Sep 30, 2024 400.00 Mn
Jun 30, 2024 487.00 Mn
Mar 31, 2024 537.00 Mn
Dec 31, 2023 281.00 Mn
Sep 30, 2023 108.00 Mn
Jun 30, 2023 392.00 Mn
Mar 31, 2023 438.00 Mn
Dec 31, 2022 486.00 Mn
Sep 30, 2022 265.00 Mn
Jun 30, 2022 338.00 Mn
Mar 31, 2022 431.00 Mn
Dec 31, 2021 655.00 Mn
Sep 30, 2021 242.00 Mn
Jun 30, 2021 502.00 Mn
Mar 31, 2021 277.00 Mn
Dec 31, 2020 981.00 Mn
Sep 30, 2020 105.00 Mn
Jun 30, 2020 277.00 Mn
Mar 31, 2020 145.00 Mn
Dec 31, 2019 240.00 Mn
Sep 30, 2019 125.00 Mn
Jun 30, 2019 413.00 Mn
Mar 31, 2019 -18.00 Mn
Dec 31, 2018 562.00 Mn
Sep 30, 2018 -173.00 Mn
Jun 30, 2018 556.00 Mn
Mar 31, 2018 -50.00 Mn
Dec 31, 2017 -174.00 Mn
Sep 30, 2017 289.00 Mn
Jun 30, 2017 -165.00 Mn
Mar 31, 2017 344.00 Mn
Dec 31, 2016 562.00 Mn
Sep 30, 2016 18.00 Mn
Jun 30, 2016 390.00 Mn
Mar 31, 2016 338.00 Mn
Dec 31, 2015 229.00 Mn
Sep 30, 2015 181.00 Mn
Jun 30, 2015 62.00 Mn
Mar 31, 2015 216.00 Mn
Dec 31, 2014 235.00 Mn
Mar 31, 2014 287.00 Mn
Dec 31, 2013 271.00 Mn
Sep 30, 2013 -222.00 Mn
Jun 30, 2013 10.00 Mn
Mar 31, 2013 -2.00 Mn
Dec 31, 2012 572.00 Mn
Sep 30, 2012 14.37 Mn
Jun 30, 2012 15.29 Mn
Mar 31, 2012 15.91 Mn
Dec 31, 2011 21.77 Mn
Sep 30, 2011 14.82 Mn
Jun 30, 2011 30.53 Mn
Mar 31, 2011 1.33 Mn
Dec 31, 2010 1.66 Mn
Sep 30, 2010 165.14 Mn
Jun 30, 2010 12.75 Mn
Mar 31, 2010 12.60 Mn
Dec 31, 2009 12.28 Mn
Sep 30, 2009 57.17 Mn
Jun 30, 2009 2.32 Mn
Mar 31, 2009 2.12 Mn